The aim of this study was to evaluate retrospectively the planned dose distribution and acute toxicity of adjuvant hypofractionated whole breast radiotherapy (RT) delivered in the prone vs. supine position.
Methods
Twenty-four patients were enrolled; 12 underwent adjuvant RT with a supine setup and 12 with a prone setup. We included patients according to breast volume (≥500 mL), disease stage (≤pT2/pN1), and clinical/biological features. Patients received a regimen of 35 Gy in 10 fractions for 2.5 weeks, and a concomitant boost of 3/4 Gy in 1 fraction/week. Target coverage was assessed by volume, V90, V95, V100, V103 and V105. Heart, LADCA and ipsilateral lung doses were evaluated according to volume, maximum dose, mean dose, V14, V10 and V5. We evaluated acute skin toxicity during RT, at the end of treatment, and after 1 month according to RTOG scales.
Results
Radiobiological equivalence was warranted with satisfactory BED values: considering α/β = 4 for breast cancer, the 10-fraction schedule equaled 74 or 77 Gy depending on the boost dose (3 Gy vs. 4 Gy, respectively). Toxicity was low and similar for supine and prone treatments. Dose sparing was significant in the ipsilateral lung in the prone position (median Dmax: 28.7 Gy vs. 38.4 Gy; median Dmean: 0.8 Gy vs. 6.3 Gy; median V14:0.6% vs. 13.5%; median V5: 0 vs. 19.3%, p<0.001).
Conclusions
This novel 10-fraction schedule is feasible and well tolerated; the prone position allows better saving of OARs, with a statistically significant value for the ipsilateral lung.
DarbyS.McGaleP.CorreaC.; Early Breast Cancer Trialists' Collaborative Group (EBCTCG). Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet.2011; 378(9804): 1707–1716.
2.
PoortmansP.M.ColletteL.BartelinkH.; EORTC Radiation Oncology and Breast Cancer Groups. The addition of a boost dose on the primary tumour bed after lumpectomy in breast conserving treatment for breast cancer: a summary of the results of EORTC 22881–10882 “boost versus no boost” trial. Cancer Radiother.2008; 12(6-7): 565–570.
3.
DarbySC. EwertzM.HallP.Ischemic heart disease and breast cancer radiotherapy: the way forward. N Engl J Med.2013; 368(26): 2527.
4.
HensonK.E.McGaleP.TaylorC.DarbyS.C.Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer.2013; 108(1): 179–182.
5.
FormentiS.C.DeWyngaertJ.K.JozsefG.GoldbergJ.D.Prone vs supine positioning for breast cancer radiotherapy. JAMA.2012; 308(9): 861–863.
6.
HuppertN.JozsefG.DewyngaertK.FormentiS.C.The role of a prone setup in breast radiation therapy. Front Oncol.2011; 1: 31.
7.
Fernéndez-LizarbeE.MonteraA.PoloA.Pilot study of feasibility and dosimetric comparison of prone versus supine breast radiotherapy. Clin Transl Oncol.2013; 15(6): 450–459.
8.
YarnoldJ.BentzenS.M.ColesC.HavilandJ.Hypofractionated whole-breast radiotherapy for women with early breast cancer: myths and realities. Int J Radiat Oncol Biol Phys.2011; 79(1): 1–9.
9.
WhelanT.J.PignolJ.P.LevineM.N.Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med.2010; 362(6): 513–520.
10.
GuenziM.VaggeS.AzinwiN.C.A biologically competitive 21 days hypofractionation scheme with weekly concomitant boost in breast cancer radiotherapy feasibility acute sub-acute and short term late effects. Radiat Oncol.2010; 5(1): 111.
11.
NielsenM.H.BergM.PedersenA.N.; Danish Breast Cancer Cooperative Group Radiotherapy Committee. Delineation of target volumes and organs at risk in adjuvant radiotherapy of early breast cancer: national guidelines and contouring atlas by the Danish Breast Cancer Cooperative Group. Acta Oncol.2013; 52(4): 703–710.
12.
FengM.MoranJ.M.KoellingT.Development and validation of a heart atlas to study cardiac exposure to radiation following treatment for breast cancer. Int J Radiat Oncol Biol Phys.2011; 79(1): 10–18.
13.
MarksL.B.YorkeE.D.JacksonA.Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys.2010; 76(3)(Suppl): S10–S19.
14.
TaylorC.W.PovallJ.M.McGaleP.Cardiac dose from tangential breast cancer radiotherapy in the year 2006. Int J Radiat Oncol Biol Phys.2008; 72(2): 501–507.
15.
BergomC.KellyT.MorrowN.Prone whole-breast irradiation using three-dimensional conformal radiotherapy in women undergoing breast conservation for early disease yields high rates of excellent to good cosmetic outcomes in patients with large and/or pendulous breasts. Int J Radiat Oncol Biol Phys.2012; 83(3): 821–828.
16.
FormentiS.C.Gidea-AddeoD.GoldbergJ.D.Phase I-II trial of prone accelerated intensity modulated radiation therapy to the breast to optimally spare normal tissue. J Clin Oncol.2007; 25(16): 2236–2242.
17.
McKinnonR.ChristieD.PeresH.BurkeM.LeT.LahM.The prone technique for breast irradiation: is it ready for clinical trials?Breast.2009; 18(1): 30–34.
18.
Fernéndez-LizarbeE.MonteraA.PoloA.Pilot study of feasibility and dosimetric comparison of prone versus supine breast radiotherapy. Clin Transl Oncol.2013; 15(6): 450–459.
19.
GriemK.L.FetherstonP.KuznetsovaM.FosterG.S.ShottS.ChuJ.Three-dimensional photon dosimetry: a comparison of treatment of the intact breast in the supine and prone position. Int J Radiat Oncol Biol Phys.2003; 57(3): 891–899.
20.
KurtmanC.Nalça AndrieuM.HiçsönmezA.CelebioğluB.Three-dimensional conformal breast irradiation in the prone position. Braz J Med Biol Res.2003; 36(10): 1441–1446.
21.
WürschmidtF.StoltenbergsKretschmerM.PetersenC.Incidental dose to coronary arteries is higher in prone than in supine whole breast irradiation: a dosimetric comparison in adjuvant radiotherapy of early stage breast cancer. Strahlenther Onkol.2014; 190(6): 563–568.
22.
CardosoM.J.CardosoJ.SantosA.C.Factors determining esthetic outcome after breast cancer conservative treatment. Breast J.2007; 13(2): 140–146.
23.
BrierleyJ.D.PatersonI.C.LallemandR.C.RostomA.Y.The influence of breast size on late radiation reaction following excision and radiotherapy for early breast cancer. Clin Oncol (R Coll Radiol).1991; 3: 6–9.
24.
MulliezT.VeldemanL.van GrevelingA.Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions. Radiother Oncol.2013; 108(2): 203–208.
25.
HavilandJ.S.OwenJ.R.DewarJ.A.; START Trialists' Group. The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials. Lancet Oncol.2013; 14(11): 1086–1094.
26.
HardeeM.E.RazaS.BeckerS.J.Prone hypofractionated whole-breast radiotherapy without a boost to the tumor bed: comparable toxicity of IMRT versus a 3D conformal technique. Int J Radiat Oncol Biol Phys.2012; 82(3): e415–e423.
27.
CammarotaF.GiuglianoF.M.ladanzaL.Hypofractionated breast cancer radiotherapy: helical tomotherapy in supine position or classic 3D-conformal radiotherapy in prone position: which is better?Anticancer Res.2014; 34(3): 1233–1238.
28.
MurthyK.K.SivakumarS.S.DavisC.A.RavichandranR.El GhamrawyK.Optimization of dose distribution with multi-leaf collimator using field-in-field technique for parallel opposing tangential beams of breast cancers. J Med Phys.2008; 33(2): 60–63.
29.
LeeJ.W.HongS.ChoiK.S.Performance evaluation of field-in-field technique for tangential breast irradiation. Jpn J Clin Oncol.2008; 38(2): 158–163.
30.
FreedmanG.M.WhiteJ.R.ArthurD.W.Allen LiX.ViciniF.A.Accelerated fractionation with a concurrent boost for early stage breast cancer. Radiother Oncol.2013; 106(1): 15–20.
31.
CorvoR.RicchettiF.DoinoD.Adjuvant hypofractionated radiotherapy with weekly concomitant boost for women with early breast cancer: the clinical experience at Genoa university. Anticancer Res.2010; 30(11): 4749–4753.
32.
MitchellJ.FormentiS.C.DeWyngaertJ.K.Interfraction and intrafraction setup variability for prone breast radiation therapy. Int J Radiat Oncol Biol Phys.2010; 76(5): 1571–1577.
33.
HuppertN.JozsefG.DewyngaertK.FormentiS.C.The role of a prone setup in breast radiation therapy. Front Oncol.2011; 1: 31.
34.
KrengliM.MasiniL.CaltavuturoT.Prone versus supine position for adjuvant breast radiotherapy: a prospective study in patients with pendulous breasts. Radiat Oncol.2013; 8(1): 232.
